Various multigene assays have been developed in an attempt to more accurately identify patients with ER+ breast cancer who will benefit from chemotherapy. Oncotype DX (Genomic Health, Redwood City, CA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback